1. Home
  2. RETO vs IMRN Comparison

RETO vs IMRN Comparison

Compare RETO & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RETO

ReTo Eco-Solutions Inc.

HOLD

Current Price

$0.69

Market Cap

9.6M

ML Signal

HOLD

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$0.89

Market Cap

7.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RETO
IMRN
Founded
1999
1994
Country
China
Australia
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
7.8M
IPO Year
2016
2016

Fundamental Metrics

Financial Performance
Metric
RETO
IMRN
Price
$0.69
$0.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.0M
23.7K
Earning Date
05-05-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$0.68
52 Week High
$4.66
$2.38

Technical Indicators

Market Signals
Indicator
RETO
IMRN
Relative Strength Index (RSI) 43.15 59.64
Support Level $0.61 $0.69
Resistance Level $1.30 $1.00
Average True Range (ATR) 0.29 0.06
MACD -0.01 0.01
Stochastic Oscillator 19.37 61.42

Price Performance

Historical Comparison
RETO
IMRN

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Machinery and Equipment sales, and Technology Consulting and other services. The company earns its revenue from the Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: